13F Notebook
← Dashboard
Fund detail

HHLR Advisors / Hillhouse (Zhang Lei)

china, growth, hillhouse, active

Quarters 31
2020-12-31 $12.58B
Positions 95
Showing 9 of 9 rows (filtered from 108)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days. PUT/CALL rows are option exposure and are marked separately.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 PINDUODUO INC PDD $1.82B 14.45% 10,230,032 +23,916 +0.23% 5.73% 2018-12-31 $178 ~$30 +486.50%
2 SALESFORCE COM INC CRM $238.6M 1.90% 1,072,095 +83,800 +8.48% 1.88% 2020-03-31 $223 ~$174 +27.85%
3 SEA LTD SE $67.2M 0.53% 337,622 +250,000 +285.32% 0.10% 2019-03-31 $199 ~$138 +43.98%
4 KEURIG DR PEPPER INC KDP $39.4M 0.31% 1,232,666 +748,598 +154.65% 0.10% 2020-06-30 $32 ~$29 +9.73%
5 FORMA THERAPEUTICS HLDGS INC $38.4M 0.31% 1,100,000 +600,000 +120.00% 0.19% 2020-06-30 $35 ~$44 -21.12%
6 CALLIDITAS THERAPEUTICS AB $35.6M 0.28% 1,047,687 +697,687 +199.34% 0.06% 2020-06-30 $34 ~$27 +25.46%
7 HUAZHU GROUP LTD HTHT $25.1M 0.20% 557,102 +428,316 +332.58% 0.04% 2019-09-30 $45 ~$42 +8.33%
8 ACM RESEARCH INC ACMR $17.4M 0.14% 214,079 +97,238 +83.22% 0.06% 2020-09-30 $81 ~$72 +13.07%
9 MEREO BIOPHARMA GROUP PLC MREO $10.7M 0.08% 2,976,121 +1,377,936 +86.22% 0.03% 2020-06-30 $4 ~$3 +20.60%